Glaucoma is a group of progressive optic nerve diseases
characterized by Elevated Intraocular Pressure (IOP), optic nerve damage, retinal ganglion cell loss, and progressive irreversible visual field loss.
It is often asymptomatic until advanced stages.
Who We Are
Oculux Diagnostics is developing a breakthrough handheld device that enables fast, accurate, and completely non-contact measurement of intraocular pressure (IOP).
Powered by proprietary technology, the system is designed to deliver clinical-grade measurements without touching the eye or requiring
anesthetic drops. By minimizing the influence of corneal thickness—a key limitation of conventional tonometry—our technology has the potential to improve
diagnostic accuracy while making glaucoma monitoring more comfortable, accessible, and scalable for patients, eye care professionals, and future home-based monitoring.
Currently, Diagnosis of Glaucoma is multi-modal and
clinician-led. Measurements are often months apart. Adherence and pressure dynamics mostly occur outside the clinic. Clinicians need concise trend summaries 2.
Our Vision
We envision a future in which glaucoma care is guided not only by occasional office measurements,
but by meaningful eye-pressure trends captured in everyday life.
Oculux is working to make non-contact home eye monitoring a practical part of proactive, personalized eye care—helping protect vision through
earlier insight and stronger collaboration between patients and clinicians.
App Driven
Provides History, Reminders, and Alerting to End Users
Trend Visability
Algorithmic Insights, Reports, and Longitudal Data Analysis
Channel flexibility
Platform capable for DTC, Telehealth and Referal Pathways
References:
1. Tham et al. (Ophthalmology 2014); GBD Vision Loss Collaborators; Market Research Future; WHO Global Report on Vision
2. American Academy of Ophthalmology Preferred Practice Pattern: Primary Open-Angle Glaucoma and POAG Suspect, 2025/2026.
